AAPS PharmSciTech

, Volume 1, Issue 2, pp 55–62 | Cite as

Effect of gramicidin on percutaneous permeation of a model drug



This study investigated the enhancement effect of gramicidin, a cationic ionophore, on percutaneous absorption of a model drug, benzoic acid (BA), through rat abdominal skin. The mechanisms by which gramicidin increased skin permeability to BA were also investigated. Degree of hydration measured by the Karl Fisher method, the concentration gradient measured by cryostat analysis, and lipid concentration measured by the. Fiske-Subbarow method were evaluated and compared. The results showed that BA permeation profiles through rat abdominal skin followed dose- and volume-dependent patterns. The pretreatment of gramicidin increased the permeation rate of BA through rat abdominal skin compared with the untreated control (18.89 vs. 10.86 μ g/cm2 hour). Change in skin permeation rate of BA after gramicidin pretreatment was closely correlated with the remaining skin water content. There were no significant differences in the amounts of phospholipid phosphorous between gramicidin pretreated and untreated skin. The enhancing effect of gramicidin on percutaneous absorption of a model drug is mainly a tributed to increasing the diffusivity in the hydration domain of the skin and rearranging the lipid bilayer in the stratum corneum.


Gramucidin Permeation Enhancer Hydration Lipid bilayer 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Yamashita F, Bando H, Koyama Y, Kitagawa S, Takakura Y, Hashida M. In vivo and in vitro analysis of skin penetration enhancement based on a two-layer model with polar and non-polar routes in the stratum comeum. Pharm Res. 1994; 11: 185–191.CrossRefPubMedGoogle Scholar
  2. 2.
    Phillips CA, Michiniak BB. Transdermal delivery of drugs with differing lipophilicities using azone analogs as dermal penetration enhances. J Pharm Sci. 1995; 84: 1427–1437.CrossRefPubMedGoogle Scholar
  3. 3.
    Flynn GL, Yalkowsky SH, Roseman TJ. Mass transport phenomena and models: theoretical concepts. J Pharm Sci. 1974; 63: 479–510.CrossRefPubMedGoogle Scholar
  4. 4.
    Ozawa T, Takahashi M. Skin hydration: Recent Advances. Acta Derm Venereol. Suppl. 1994; 185: 26–28.Google Scholar
  5. 5.
    Iazzo PA, Olsen RA, Seewald MJ, Powis G, Stier A, Van Dyke RA. Transient increases of intracellular Ca++ induced by volatile anesthetics in rat hepatocytes. Cell Calcium. 1990; 11: 515–524.CrossRefGoogle Scholar
  6. 6.
    Reed PW, Lardy HA. A23187: Adivalent Cationionophore. J Biol Chem. 1972; 247: 6970.PubMedGoogle Scholar
  7. 7.
    Wallace BA. Gramicidin channels and pores. Ann Rev Biophysic Chem. 1990; 19: 127.CrossRefGoogle Scholar
  8. 8.
    Araki M, Inaba H, Kon S, Imai M, Mizuguchi T. Effects of volatile anesthetics on the calcium ionophore A23187-mediated alterations in hepatic flow and metabolism in the perfused liver in fasted rats. Acta Anesthesiol Scan. 1997; 41: 55–61.CrossRefGoogle Scholar
  9. 9.
    Plakas SM, James MO. Bioavailability, metabolism, and renal excretion of benzoic acid in the channel cattish (Ictalurus punctatus). Drug Metab Dispos. 1990; 18(5): 552–556.PubMedGoogle Scholar
  10. 10.
    French DL, Haglund BO, Himmelstein KJ, Mauger JW: Controlled release of substituted benzoic and naphthoic acids using Carbopol gels: measurement of drug concentration profiles and correlation to release rate kinetics. Pharm Res. 1995; 12(10): 1513–1520.CrossRefPubMedGoogle Scholar
  11. 11.
    Miller GR, Smith CA, Stauber WT. Determination of fibrosis from cryostat sections using high performance liquid chromatography: skeletal muscle. Histochem J. 1999; 31: 89–94.CrossRefPubMedGoogle Scholar
  12. 12.
    Bartlett GR. Phosphorous assay in column chromatography. J Biol Chem. 1959; 234: 466–468.PubMedGoogle Scholar
  13. 13.
    Kabadi MB, Chien YW. Intravaginal controlled administration of flurogestone acetate IV:in-vitro andin-vivo correlation for intravaginal drug delivery from rate-control vaginal pessary. Drug Develop Ind Pharm. 1985; 11: 1313–1361.CrossRefGoogle Scholar
  14. 14.
    Lee CH, Vyavahare N, Zand R, Kruth H, Schoen FJ, Bianco R, Levy RJ. Inhibition of aortic wall calcification in bioprosthetic heart valves by ethanol pretreatment: Biochemical and biophysical mechanisms. J Biomed Mater Res. 1998; 42(1): 30–37.CrossRefPubMedGoogle Scholar
  15. 15.
    Hu W, Cross TA. Tryptophan hydrogen bonding and electric dipole moments: functional roles in the gramicidin channel and implications for membrane proteins. Biochemistry. 1995; 34: 14.147–14.155.CrossRefGoogle Scholar
  16. 16.
    Heitz F, Gavach C. Ca+2 gramicidin A interactions and blocking effects on the ionic channel. Biophysical Chemistry. 1983; 18: 153–163.CrossRefPubMedGoogle Scholar
  17. 17.
    Mitchell DC, Litman BJ. Effect of hydration on receptor conformation: decreased levels of bound water promote metarhodopsin II formation. Biochemistry. 1999; 38: 7617–7623.CrossRefPubMedGoogle Scholar
  18. 18.
    Kuruc M, Krupey J. Application of an insoluble protein precipitation reagent. Am Biotechnol 1992; 10(3): 12–14.Google Scholar
  19. 19.
    Hwang J, Tamm LK, Bohm C, Ramalingam TS, Betzig E, Edidin M. Nanoscale complexity of phospholipid monolayers investigated by near-field scanning optical microscopy. Science. 1995; 270: 610–614CrossRefPubMedGoogle Scholar
  20. 20.
    Carruthers A, Melchior DL. Human erythrocyte hexose transporter activity is governed by bilayer lipid composition in reconstituted vesicles. Biochemistry. 1984; 23(26): 6901–6911.CrossRefPubMedGoogle Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2000

Authors and Affiliations

  1. 1.Department of PharmaceuticsThe University of Missouri-Kansas CityKansas City
  2. 2.College of PharmacyChosun UniversityKwangjuKorea

Personalised recommendations